91AV

Introduction

Our Organ Modelling Congress addresses an important and expanding field which provides new understandings in organ functionality and novel approaches to drug development. These engineered human organs using Organ-on-a-Chip, Tissue-on-a-Chip & Organoids are a remarkable tool with the potential to facilitate studies that better predict drug efficacy and thereby reduce cost, time, and failure rates in clinical trials. Further, patient-derived organoids hold promise for personalised medicine, as they have the potential to produce individualised predictions of drug response.

Useful links

Speakers

• Hansjoerg Keller Novartis Institutes for BioMedical Research, United Kingdom
• Linda Lieberman Merck & Co, United Kingdom
• Pelin Candarlioglu GlaxoSmithKline, United Kingdom
• Ron Weiss MIT, United Kingdom
• Sasha Mendjan IMBA Institute Of Molecular Biotechnology, United Kingdom
• Olivier T. Guenat University of Bern, United Kingdom

---

Venue

Novotel London West

Novotel London West, 1 Shortlands, Hammersmith International Centre, Hammersmith, London, W6 8DR, United Kingdom

Useful links

Organised by

Oxford Global

Contact information

Guillaume Alonso
Oxford Global
Contact us by email

---